398 related articles for article (PubMed ID: 1664758)
1. Quantitative assessment of increased airway microvascular permeability to 125I-labelled plasma fibrinogen induced by platelet activating factor and bradykinin.
Pedersen KE; Rigby PJ; Goldie RG
Br J Pharmacol; 1991 Sep; 104(1):128-32. PubMed ID: 1664758
[TBL] [Abstract][Full Text] [Related]
2. Effect of Y-24180, a platelet-activating factor-receptor antagonist, on the antigen-induced airway microvascular leakage in guinea pigs.
Iwahisa Y; Yamaguchi S; Kagoshima M; Terasawa M
Jpn J Pharmacol; 1996 Nov; 72(3):209-15. PubMed ID: 8957681
[TBL] [Abstract][Full Text] [Related]
3. The effect of the selective PAF antagonist CIS-19 on PAF- and antigen-induced bronchoconstriction, microvascular leakage and bronchial hyperreactivity in guinea-pigs.
Lin CH; Ko FN; Ishii H; Ishikawa T; Chen IS; Teng CM; Kuo HP
Naunyn Schmiedebergs Arch Pharmacol; 1997 Feb; 355(2):210-6. PubMed ID: 9050014
[TBL] [Abstract][Full Text] [Related]
4. Platelet-activating factor mediates the ozone-induced increase in airway microvascular leakage in guinea pigs.
Kaneko T; Ikeda H; Fu L; Nishiyama H; Okubo T
Eur J Pharmacol; 1995 Mar; 292(3-4):251-5. PubMed ID: 7796863
[TBL] [Abstract][Full Text] [Related]
5. Effect of Hoe 140, a new bradykinin receptor antagonist, on bradykinin- and platelet-activating factor-induced bronchoconstriction and airway microvascular leakage in guinea pig.
Sakamoto T; Elwood W; Barnes PJ; Chung KF
Eur J Pharmacol; 1992 Mar; 213(3):367-73. PubMed ID: 1319919
[TBL] [Abstract][Full Text] [Related]
6. Bradykinin-induced plasma exudation in guinea-pig airways: involvement of platelet activating factor.
Rogers DF; Dijk S; Barnes PJ
Br J Pharmacol; 1990 Nov; 101(3):739-45. PubMed ID: 2076490
[TBL] [Abstract][Full Text] [Related]
7. Microvascular leakage to platelet activating factor in guinea-pig trachea and bronchi.
O'Donnell SR; Barnett CJ
Eur J Pharmacol; 1987 Jun; 138(3):385-96. PubMed ID: 3040440
[TBL] [Abstract][Full Text] [Related]
8. Effect of inhaled lyso-platelet-activating factor on airway microvascular leakage in the guinea pig.
Sakamoto T; Elwood W; Barnes PJ; Chung KF
J Appl Physiol (1985); 1993 Mar; 74(3):1117-22. PubMed ID: 8482649
[TBL] [Abstract][Full Text] [Related]
9. Effects of endothelin-1 on vascular permeability in the conscious rat: interactions with platelet-activating factor.
Filep JG; Sirois MG; Rousseau A; Fournier A; Sirois P
Br J Pharmacol; 1991 Dec; 104(4):797-804. PubMed ID: 1667286
[TBL] [Abstract][Full Text] [Related]
10. Effect of a Paf antagonist, WEB 2086, on airway microvascular leakage in the guinea-pig and platelet aggregation in man.
Evans TW; Dent G; Rogers DF; Aursudkij B; Chung KF; Barnes PJ
Br J Pharmacol; 1988 May; 94(1):164-8. PubMed ID: 3401633
[TBL] [Abstract][Full Text] [Related]
11. Rolipram inhibits airway microvascular leakage induced by platelet-activating factor, histamine and bradykinin in guinea-pigs.
Ortiz JL; Cortijo J; Vallés JM; Bou J; Morcillo EJ
J Pharm Pharmacol; 1993 Dec; 45(12):1090-2. PubMed ID: 7908981
[TBL] [Abstract][Full Text] [Related]
12. Regional and time-dependent effects of inflammatory mediators on airway microvascular permeability in the guinea pig.
Evans TW; Rogers DF; Aursudkij B; Chung KF; Barnes PJ
Clin Sci (Lond); 1989 May; 76(5):479-85. PubMed ID: 2721114
[TBL] [Abstract][Full Text] [Related]
13. PAF receptors in guinea-pig and human lung.
Goldie RG; Pedersen KE; Rigby PJ; Paterson JW
Agents Actions Suppl; 1990; 31():243-6. PubMed ID: 1964365
[TBL] [Abstract][Full Text] [Related]
14. Early and late tracheobronchial plasma exudation by platelet-activating factor administered to the airway mucosal surface in guinea pigs: effects of WEB 2086 and enprofylline.
O'Donnell SR; Erjefält I; Persson CG
J Pharmacol Exp Ther; 1990 Jul; 254(1):65-70. PubMed ID: 2366192
[TBL] [Abstract][Full Text] [Related]
15. Effects of WEB 2086, an antagonist to the receptor for platelet-activating factor (PAF), on PAF-induced responses in the horse.
Foster AP; Lees P; Andrews MJ; Cunningham FM
Equine Vet J; 1992 May; 24(3):203-7. PubMed ID: 1318830
[TBL] [Abstract][Full Text] [Related]
16. Effect of platelet-activating factor on airway vascular permeability: possible mechanisms.
Evans TW; Chung KF; Rogers DF; Barnes PJ
J Appl Physiol (1985); 1987 Aug; 63(2):479-84. PubMed ID: 3115939
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of airway narrowing caused by inhaled platelet-activating factor. Role of airway microvascular leakage.
Tokuyama K; Lötvall JO; Barnes PJ; Chung KF
Am Rev Respir Dis; 1991 Jun; 143(6):1345-9. PubMed ID: 2048823
[TBL] [Abstract][Full Text] [Related]
18. Effect of Y-24180, a long-acting antagonist to platelet-activating factor (PAF), on PAF-induced reactions: a relationship between the partial structure of the compound and its duration of the action.
Kagoshima M; Tomomatsu N; Iwahisa Y; Yamaguchi S; Kawakami Y; Terasawa M
Pharmacology; 1997 May; 54(5):261-70. PubMed ID: 9380772
[TBL] [Abstract][Full Text] [Related]
19. Characterization of specific binding sites of 3H-labelled platelet-activating factor ([3H]PAF) and a new antagonist, [3H]SR 27417, on guinea-pig tracheal epithelial cells.
Herbert JM
Biochem J; 1992 May; 284 ( Pt 1)(Pt 1):201-6. PubMed ID: 1318021
[TBL] [Abstract][Full Text] [Related]
20. Inhibitor effect of apafant on bronchopulmonary responses to platelet activating factor and to antigen in rats.
Akagi M; Nishioka E; Kanoh R; Tachibana M; Fukuishi N
Arzneimittelforschung; 1997 Dec; 47(12):1364-9. PubMed ID: 9450165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
